RxDoctor Payments Data

Cyrus Loghmanee, MD

Plastic Surgery · Hoboken, NJNPI 1831365303

Payments from drug & device makers

What this record shows

AbbVie accounts for 83.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $2,164 and has fallen 87.5% since, to $271 in 2025.

$3,873in general payments, 2019–2025

Across 36 payments — averaging $107.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Tepha Inc$179
  • Axogen$161
  • Kerecis Limited$143
  • Regeneron Healthcare Solutions, Inc.$109
  • Mentor Worldwide LLC$44
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$2,12355%
  • Gifts$1,75045%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,873 in reported general payments places this provider in the 70th percentile of 170 plastic surgery providers in New Jersey.

See all plastic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$10,822
Medicare patients
11
Services billed
25

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic surgery in Hoboken

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →